Back
OptimizeRx Corp. 10K Form
Sell
29
OPRX
OptimizeRx Corp.
Last Price:
$14.66
Seasonality Move:
12.2%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2020-08-05 | 10Q | OPRX/OptimizeRx Corp. Quarterly |
| 2020-05-06 | 10Q | OPRX/OptimizeRx Corp. Quarterly |
| 2020-03-26 | 10K | OPRX/OptimizeRx Corp. Annual |
| 2019-11-05 | 10Q | OPRX/OptimizeRx Corp. Quarterly |
| 2019-08-07 | 10Q | OPRX/OptimizeRx Corp. Quarterly |
| 2019-05-08 | 10Q | OPRX/OptimizeRx Corp. Quarterly |
Receive OPRX News And Ratings
See the #1 stock for the next 7 days that we like better than OPRX
OPRX Financial Statistics
Sales & Book Value
| Annual Sales: | $92.1M |
|---|---|
| Cash Flow: | $3.2M |
| Price / Cash Flow: | 23.36 |
| Annual Sales: | $6.58 |
| Price / Book: | 2.23 |
Profitability
| EPS (TTM): | -0.00260 |
|---|---|
| Net Income (TTM): | $35K |
| Gross Margin: | $55M |
| Return on Equity: | 0.03% |
| Return on Assets: | 0.02% |
OptimizeRx Corp. Earnings Forecast
Key OptimizeRx Corp. Financial Ratios
-
The Gross Profit Margin over the past 18 years for OPRX is 59.75%.
-
The Selling, General & Administrative Expenses for OPRX have been equal to 54.05% of Gross Profit Margin.
-
The Research & Development expenses have been 2.49% of Revenue.
-
The Net Earning history of OPRX is -21.83% of Total Revenues.
-
Per Share Earnings over the last 18 years have been positive in 8 years.
OptimizeRx Corp. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Health Care Technology |
| Sector: | Health Care |
| Current Symbol: | OPRX |
| CUSIP: | 68401U |
| Website: | optimizerx.com |
Debt
| Debt-to-Equity Ratio: | 0.23 |
|---|---|
| Current Ratio: | 3.05 |
| Quick Ratio: | 2.82 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 16.98 |
OPRX Technical Analysis vs Fundamental Analysis
Sell
29
OptimizeRx Corp. (OPRX)
is a Sell
Is OptimizeRx Corp. a Buy or a Sell?
-
OptimizeRx Corp. stock is rated a SellThe current OptimizeRx Corp. [OPRX] share price is $14.65. The Score for OPRX is 29, which is 42% below its historic median score of 50, and infers higher risk than normal.